What defines intermediate-risk prostate cancer? Variability in published prognostic models

Author： Williams S.G.   Millar J.L.   Dally M.J.   Sia S.   Miles W.   Duchesne G.M.  

Publisher： Elsevier

ISSN： 0360-3016

Source： International Journal of Radiation Oncology*Biology*Physics, Vol.58, Iss.1, 2004-01, pp. : 11-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

What Is the Risk Posed by Prostate Cancer?

By Albertsen Peter C.  

Journal of the National Cancer Institute Monographs, Vol. 2012, Iss. 45, 2012-09 ,pp. : 169-174

Oxford University Press

Access to resources Recommend Favorite

Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer

By Nixon Iain J   Ganly Ian  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 921-923

Future Medicine

Access to resources Recommend Favorite

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

By                            

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 881-885

Spandidos Publications

Access to resources Recommend Favorite

Treatment for intermediate and high-risk prostate cancer: Controversial issues and the role of hyperthermia

By Maluta Sergio   Dall'oglio Stefano   Nadalini Luisa  

International Journal of Hyperthermia, Vol. 26, Iss. 8, 2010-12 ,pp. : 765-774

Informa Healthcare

Access to resources Recommend Favorite

Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer

By Ishkanian Adrian S.   Zafarana Gaetano   Thoms John   Bristow Robert G.  

Acta Oncologica, Vol. 49, Iss. 7, 2010-10 ,pp. : 888-894

Informa Healthcare

Access to resources Recommend Favorite